S&P 500   0.57 (+2.14%)
DOW   0.57 (+2.14%)
QQQ   270.31 (-0.43%)
AAPL   450.91 (+1.45%)
MSFT   208.25 (-1.99%)
FB   263.00 (-2.03%)
GOOGL   1,496.82 (-0.10%)
AMZN   3,148.16 (-0.61%)
NVDA   446.60 (-0.31%)
CGC   17.93 (+7.82%)
BABA   248.13 (-1.57%)
TSLA   1,418.57 (-2.35%)
GE   6.67 (+4.22%)
MU   49.15 (+0.82%)
AMD   82.24 (-3.08%)
T   30.20 (+0.60%)
F   7.09 (+3.35%)
ACB   10.22 (-0.49%)
GILD   68.51 (-1.21%)
NFLX   483.38 (-2.29%)
DIS   128.79 (-0.88%)
BAC   26.56 (+1.72%)
BA   179.41 (+5.52%)
S&P 500   0.57 (+2.14%)
DOW   0.57 (+2.14%)
QQQ   270.31 (-0.43%)
AAPL   450.91 (+1.45%)
MSFT   208.25 (-1.99%)
FB   263.00 (-2.03%)
GOOGL   1,496.82 (-0.10%)
AMZN   3,148.16 (-0.61%)
NVDA   446.60 (-0.31%)
CGC   17.93 (+7.82%)
BABA   248.13 (-1.57%)
TSLA   1,418.57 (-2.35%)
GE   6.67 (+4.22%)
MU   49.15 (+0.82%)
AMD   82.24 (-3.08%)
T   30.20 (+0.60%)
F   7.09 (+3.35%)
ACB   10.22 (-0.49%)
GILD   68.51 (-1.21%)
NFLX   483.38 (-2.29%)
DIS   128.79 (-0.88%)
BAC   26.56 (+1.72%)
BA   179.41 (+5.52%)
S&P 500   0.57 (+2.14%)
DOW   0.57 (+2.14%)
QQQ   270.31 (-0.43%)
AAPL   450.91 (+1.45%)
MSFT   208.25 (-1.99%)
FB   263.00 (-2.03%)
GOOGL   1,496.82 (-0.10%)
AMZN   3,148.16 (-0.61%)
NVDA   446.60 (-0.31%)
CGC   17.93 (+7.82%)
BABA   248.13 (-1.57%)
TSLA   1,418.57 (-2.35%)
GE   6.67 (+4.22%)
MU   49.15 (+0.82%)
AMD   82.24 (-3.08%)
T   30.20 (+0.60%)
F   7.09 (+3.35%)
ACB   10.22 (-0.49%)
GILD   68.51 (-1.21%)
NFLX   483.38 (-2.29%)
DIS   128.79 (-0.88%)
BAC   26.56 (+1.72%)
BA   179.41 (+5.52%)
S&P 500   0.57 (+2.14%)
DOW   0.57 (+2.14%)
QQQ   270.31 (-0.43%)
AAPL   450.91 (+1.45%)
MSFT   208.25 (-1.99%)
FB   263.00 (-2.03%)
GOOGL   1,496.82 (-0.10%)
AMZN   3,148.16 (-0.61%)
NVDA   446.60 (-0.31%)
CGC   17.93 (+7.82%)
BABA   248.13 (-1.57%)
TSLA   1,418.57 (-2.35%)
GE   6.67 (+4.22%)
MU   49.15 (+0.82%)
AMD   82.24 (-3.08%)
T   30.20 (+0.60%)
F   7.09 (+3.35%)
ACB   10.22 (-0.49%)
GILD   68.51 (-1.21%)
NFLX   483.38 (-2.29%)
DIS   128.79 (-0.88%)
BAC   26.56 (+1.72%)
BA   179.41 (+5.52%)
Log in

NYSE:BEAMBeam Suntory Stock Price, Forecast & News

Notice: This company has been marked as potentially delisted and may not be actively trading.
$24.10
+0.63 (+2.68 %)
(As of 08/10/2020 04:00 PM ET)
Add
Compare
Today's Range
$23.86
Now: $24.10
$24.50
50-Day Range N/A
52-Week Range N/A
Volume655,039 shs
Average VolumeN/A
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A
Beam Therapeutics Inc., a biotechnology company, engages in developing precision genetic medicines for patients suffering from serious diseases in the United States. It is developing therapies for the development of sickle cell disease and beta-thalassemia; CAR-T cell therapies for pediatric T-cell acute lymphoblastic leukemia and pediatric acute myeloid leukemia; therapies for alpha-1 antitrypsin deficiency and glycogen storage disorder 1A; and therapies for ocular and central nervous system disorders. The company was founded in 2017 and is based in Cambridge, Massachusetts.
Read More
Beam Suntory logo

Beat the Market (BTM) Rank

Analyst Opinion: 3.5Community Rank: 2.1Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

1.12 out of 5 stars


Industry, Sector and Symbol

Industry Biotechnology
Sub-IndustryDistillers & Vintners
SectorMedical
CUSIP07373010
Phone+1-312-9646999

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesN/A

Profitability

Miscellaneous

EmployeesN/A
Next Earnings DateN/A
OptionableNot Optionable

Receive BEAM News and Ratings via Email

Sign-up to receive the latest news and ratings for BEAM and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Beam Suntory (NYSE:BEAM) Frequently Asked Questions

Do Wall Street analysts recommend investors buy shares of Beam Suntory?

5 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Beam Suntory in the last year. There are currently 5 buy ratings for the stock, resulting in a consensus recommendation of "Buy."
View analyst ratings for Beam Suntory
.

How were Beam Suntory's earnings last quarter?

Beam Suntory Inc (NYSE:BEAM) issued its quarterly earnings data on Tuesday, May, 12th. The company reported ($1.03) EPS for the quarter, missing analysts' consensus estimates of ($0.51) by $0.52. The business earned $0.01 million during the quarter.
View Beam Suntory's earnings history
.

What price target have analysts set for BEAM?

5 brokerages have issued 1-year price objectives for Beam Suntory's stock. Their forecasts range from $31.00 to $33.00. On average, they expect Beam Suntory's share price to reach $32.00 in the next year. This suggests a possible upside of 32.8% from the stock's current price.
View analysts' price targets for Beam Suntory
.

Has Beam Suntory been receiving favorable news coverage?

Headlines about BEAM stock have trended somewhat negative recently, according to InfoTrie Sentiment Analysis. The research firm identifies negative and positive media coverage by monitoring more than six thousand news and blog sources. The firm ranks coverage of public companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. Beam Suntory earned a daily sentiment score of -1.9 on InfoTrie's scale. They also gave press coverage about the company a news buzz of 0.0 out of 10, meaning that recent media coverage is extremely unlikely to have an impact on the stock's share price in the near term.
View the latest news about Beam Suntory
.

Who are some of Beam Suntory's key competitors?

What other stocks do shareholders of Beam Suntory own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Beam Suntory investors own include salesforce.com (CRM), AT&T (T), Adobe (ADBE), Akamai Technologies (AKAM), Applied Materials (AMAT), Bank of America (BAC), Dollar General (DG), Intel (INTC), JPMorgan Chase & Co. (JPM) and Starbucks (SBUX).

Who are Beam Suntory's key executives?

Beam Suntory's management team includes the following people:
  • Mr. John M. Evans, CEO & Director (Age 42, Pay $473.53k)
  • Dr. Giuseppe Ciaramella, Pres & Chief Scientific Officer (Age 51, Pay $432.45k)
  • Dr. Feng Zhang, Co-Founder
  • Ms. Terry-Ann Burrell, CFO & Treasurer (Age 42, Pay $456.6k)
  • Dr. David R. Liu, Co-Founder

When did Beam Suntory IPO?

(BEAM) raised $101 million in an IPO on Thursday, February 6th 2020. The company issued 6,300,000 shares at $15.00-$17.00 per share. J.P. Morgan, Jefferies and Barclays served as the underwriters for the IPO and Wedbush PacGrow was co-manager.

What is Beam Suntory's stock symbol?

Beam Suntory trades on the New York Stock Exchange (NYSE) under the ticker symbol "BEAM."

When did the company's lock-up period expire?

Beam Suntory's lock-up period expired on Tuesday, August 4th. Beam Suntory had issued 10,588,236 shares in its IPO on February 6th. The total size of the offering was $180,000,012 based on an initial share price of $17.00. Shares of the company owned by company insiders and major shareholders are now eligible to be traded as a result of the end of the lock-up period.

Who are Beam Suntory's major shareholders?

Beam Suntory's stock is owned by a variety of institutional and retail investors. Top institutional investors include Swiss National Bank (0.00%), New York State Common Retirement Fund (0.00%), UBS Group AG (0.00%), SG Americas Securities LLC (0.00%), Harbor Investment Advisory LLC (0.00%) and Endurance Wealth Management Inc. (0.00%).

Which institutional investors are buying Beam Suntory stock?

BEAM stock was purchased by a variety of institutional investors in the last quarter, including Swiss National Bank, New York State Common Retirement Fund, SG Americas Securities LLC, UBS Group AG, Harbor Investment Advisory LLC, and Endurance Wealth Management Inc..

What is Beam Suntory's stock price today?

One share of BEAM stock can currently be purchased for approximately $24.10.

What is Beam Suntory's official website?

The official website for Beam Suntory is www.beamsuntory.com.

How can I contact Beam Suntory?

Beam Suntory's mailing address is 222 Merchandise Mart Plz Ste 1600, CHICAGO, IL 60654-4262, United States. The company can be reached via phone at +1-312-9646999.

This page was last updated on 8/10/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.